On the relationship of OSW-1 to the cephalostatins

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 3, 1999, Pages 419-424

  Guo, Chuangxing ^a   LaCour, Thomas G ^a   Fuchs, P L ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE DERIVATIVE; ANTINEOPLASTIC AGENT; CEPHALOSTATIN; NATURAL PRODUCT; SAPONIN; SAPONIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; PHARMACOPHORE; REACTION ANALYSIS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHOLESTENONES; SAPONINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033535077     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00743-4     Document Type: Article

References (20)

1. Pettit, G. R.; Tan, R.; Xu, J.-P.; Ichihara, Y.; Williams, M. D.; Boyd, M. R. J. Nat. Prod. 1998, 61, 953.
2. Fukuzawa, S.; Matsunaga, S.; Fusetani, N. J. Org. Chem. 1997, 62, 4484 and references cited therein.
3. Mimaki, Y.; Kuroda, M.; Kameyama, A.; Sashida, Y.; Hirano, T.; Oka, K.; Maekawa, R.; Wada, T.; Sugita, K.; Beutler, J. A. Bioorg. & Med. Chem. Lett. 1997, 7, 633 and references therein.
4. Guo, C.; Fuchs, P. L. Tetrahedron Lett. 1998, 39, 1099.
5. LaCour, T. G.; Guo, C.; Boyd, M. R.; Fuchs, P. L. Bioorg. Med. Chem. Lett, submitted.
6. LaCour, T. G.; Guo, C.; Bhandaru, S.; Boyd, M. R.; Fuchs, P. L. J. Am. Chem. Soc. 1998, 120, 692.
7. Kim, S.; Sutton, S.; Guo, C.; LaCour, T. G.; Fuchs, P. L. J. Am. Chem. Soc., in press, and refs 6 and 13.
8. The naming system reflects the origins of the steroidal units: 'Ornitho' from Ornithogalum saundersiae, 'statin' from cephalostatin and 'ritter' or 'zine' from ritterazine, in keeping with the system adopted for the earlier hybrid ritterostatins (ref 6).
9. The NMR of 8a showed a single diastereomer and was consistent with that of related 22S compounds. The 22S configuration was also calculated to be 2.2 kcal/mol more stable than the 22R epimer (CAChe v.3.5).
10. 13C NMR spectra, MS and HRMS.
11. Li, C.; Shih, T. L.; Jeong, J. U.; Arasappan, A.; Fuchs, P. L. Tetrahedron Lett. 1994, 35, 2645.
12. Reuss, R. H.; Hassner, A. J. Org. Chem. 1974, 39, 1785.
13. Guo, C.; Bhandaru, S.; Fuchs, P. L.; Boyd, M. R. J. Am. Chem. Soc. 1996, 118, 10672.
14. Mosmann, T. J. Immuno. Methods 1983, 65, 55-63, and Alley, M. C.; Scudiero, D. A.; Monks, A.; Hursey, M. L.; Czerwinski, M. J.; Fine, D. L.; Abbott, B. J.; Mayo, J. G.; Shoemaker, R. H.; Boyd, M. R. Cancer Res. 1988, 48, 589.
15. Mosmann, T. J. Immuno. Methods 1983, 65, 55-63, and Alley, M. C.; Scudiero, D. A.; Monks, A.; Hursey, M. L.; Czerwinski, M. J.; Fine, D. L.; Abbott, B. J.; Mayo, J. G.; Shoemaker, R. H.; Boyd, M. R. Cancer Res. 1988, 48, 589.
16. TLC indicated some formation of 8b when a chloroform solution of 8a was allowed to stand for 20h.
17. Conceivably, protonation of the 16αOH in 11 or 12 and β face attack by ketal or ketone oxygen could lead to a hemiketal and an E-ring oxocarbenium ion. However, we have observed no evidence for such reaction in either 12 nor 20 upon standing in acidic chloroform.
18. (a) Jeong, J. U.; Fuchs, P. L. Tetrahedron Lett. 1995, 36, 2431; (b) Jeong, J. U.; Guo, C.; Fuchs, P. L. J. Am. Chem. Soc. in press.
19. (a) Jeong, J. U.; Fuchs, P. L. Tetrahedron Lett. 1995, 36, 2431; (b) Jeong, J. U.; Guo, C.; Fuchs, P. L. J. Am. Chem. Soc. in press.
20. Caspar, D. L. D. and Kirschner, D. A. Nature:NB 1971, 231, 46.